Association Between Personality Traits and Onabotulinumtoxin A Response in Patients With Chronic Migraine-Reference-Cited by-同舟云学术

Association Between Personality Traits and Onabotulinumtoxin A Response in Patients With Chronic Migraine

Published:2019-11-06 Issue:1 Volume:60 Page:153-161
ISSN:0017-8748
Container-title:Headache: The Journal of Head and Face Pain
language:en
Short-container-title:Headache: The Journal of Head and Face Pain

Author:

Gonzalez‐Martinez Alicia¹^ORCID,Rodríguez Vázquez Eva²,Red Gallego Henar²,García‐Azorín David²,Gallego de La Sacristana Mercedes¹,Guerrero Peral Ángel Luis²³,Gago‐Veiga Ana Beatriz¹

Affiliation:

1. Headache Unit Neurology Department Hospital Universitario de La Princesa & Instituto de Investigación Sanitaria de La Princesa Madrid Spain

2. Headache Unit Neurology Department Hospital Clínico Universitario de Valladolid Valladolid Spain

3. Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/head.13693

Reference35 articles.

1. Personality Traits, Depression and Migraine in Women: A Longitudinal Study

2. Personality in patients with migraine evaluated with the "Temperament and Character Inventory"

3. Personality disorders in cluster headache: a study using the Millon Clinical Multiaxial Inventory-III

4. Global prevalence of chronic migraine: A systematic review

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personality in Chronic Headache: A Systematic Review with Meta-Analysis;Pain Research and Management;2023-08-28

2. Effectiveness and Safety of Chronic Migraine Preventive Treatments: A Systematic Literature Review;Pain and Therapy;2022-11-22

3. Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data;Cephalalgia;2022-09-08

4. Clinical effect of flunarizine combined with duloxetine in the treatment of chronic migraine comorbidity of depression and anxiety disorder;Brain and Behavior;2022-07-05

5. Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown;Neurological Sciences;2021-03-26